Public Market Listing
1541HKEX
Live quotes, historical charts, and market capitalization for ImmuneOnco Biopharmaceuticals are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | PD-L1 / VEGFMultispecific antibody | Non-Small Cell Lung Cancer | |
| Phase 1/2 | Activin receptor type IIA (ActRIIA)Biologic (subtype unspecified) | Indication not yet linked |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.